Table 1.
Description of the 3 cohorts BM (N = 1268), UM (N = 503), and RTOG (N = 615), categorical variable shown as number (frequency), and continuous variables as mean (standard deviation)
| Variable |
BM | UM | RTOG | |
| (N = 1268) | (N = 503) | (N = 615) | ||
| Event | 190 (15.0) | 85 (16.9) | 42 (6.8) | |
| T-stage | 1 | 431 (34.0) | 163 (32.4) | 348 (56.6) |
| 2 | 792 (62.5) | 290 (57.7) | 253 (41.1) | |
| 3, 4 | 45 (3.5) | 50 (9.9) | 14 (2.3) | |
| Gleason | < 7 | 902 (71.1) | 276 (54.9) | 421 (68.4) |
| 7 | 252 (19.9) | 188 (37.4) | 156 (25.4) | |
| > 7 | 114 (9.0) | 39 (7.7) | 38 (6.2) | |
| Hormonal therapy | 170 (13.4) | 44 (8.8) | 47 (7.6) | |
| ln(iPSA + 0.1) (ln(ng/mL)) | 2.16 (0.84) | 2.23 (0.92) | 2.00 (0.61) | |
| Age (years) | 72.7 (6.5) | 69.0 (7.1) | 68.0 (7.0) | |
| Time to recurrence (years) | 5.03 (2.71) | 3.82 (2.49) | 4.61 (2.00) | |
| Time to last contact (years) | 5.91 (3.30) | 6.21 (3.41) | 5.92 (2.03) | |